Category Business News

Innovent Wins China Drug Award Nuvation Bio (NUVB:NYSE)

kemalbas/iStock via Getty Images Innovent Biologics (OTCPK:IVBIY) announced that Chinese regulators approved its second marketing application for lung cancer therapy, Dovbleron, developed with US biotech Nuvation Bio (NYSE:NUVB). The Chinese biotech company announced late Thursday that China's National Medical Products…